Gastrointestinal Cancer News

Upfront tumor screening for Lynch syndrome appeared simpler and demonstrated superior sensitivity than the current multiple sequential test approach among patients with colorectal cancer, study data showed.

Patients with alcohol-related hepatocellular carcinoma appeared to have worse prognosis than those with nonalcohol-related disease, according to study findings published in Cancer.

Patients with head and neck cancers appeared significantly more likely to receive opioid prescriptions than those who had lung cancer or colon cancer, according to a published research letter.

The FDA granted priority review to nivolumab plus ipilimumab for the treatment of adults with microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer that has progressed following treatment with fluoropyrimidine, oxaliplatin and irinotecan, according to a manufacturer-issued press release.

Health care providers appeared significantly less likely to recommend the HPV vaccine to boys than girls, according to study results presented at the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

While hepatitis C screening improved recently, the increased rates are minimal and less than optimal among black individuals, Hispanics and women, according to a recently published study.

Cabozantinib significantly extended OS for patients with previously treated advanced hepatocellular carcinoma, according to results from the randomized, double-blind, placebo-controlled phase 3 Celestial trial.

Click here to read the Cover Story, “As use of robotic surgery increases, training and regulation become more rigorous.”

Robotic-assisted surgery has served as an alternative minimally invasive surgical option for patients with cancer for more than a decade.

Researchers developed a predictive risk score for the development hepatocellular carcinoma during oral antiviral therapy in patients with chronic hepatitis B, according to recently published data.